Evidence map›Paper›PMID 39280551›Full record

ArticleCureus2024

Efficacy of S-Flurbiprofen Plaster for Analgesia Following Total Hip Arthroplasty.

Yoshiaki Miyake, Shigeru Mitani, Yoshifumi Namba, Norifumi Umehara, Toyohiro Kawamoto, Shuro Furuichi

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yoshiaki MiyakeBone and Joint Surgery, Kawasaki Medical School, Kurashiki, JPN.
Shigeru MitaniBone and Joint Surgery, Kawasaki Medical School, Kurashiki, JPN.
Yoshifumi NambaBone and Joint Surgery, Kawasaki Medical School, Kurashiki, JPN.
Norifumi UmeharaBone and Joint Surgery, Kawasaki Medical School, Kurashiki, JPN.
Toyohiro KawamotoBone and Joint Surgery, Kawasaki Medical School, Kurashiki, JPN.
Shuro FuruichiBone and Joint Surgery, Kawasaki Medical School, Kurashiki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeS-flurbiprofen (SFP) plaster, a non-steroidal anti-inflammatory drug preparation that penetrates effectively into deep tissue, is currently used as a conservative treatment for osteoarthritis. We investigated the analgesic and adverse effects of SFP plaster after total hip arthroplasty (THA).

methodsA retrospective comparative study identified 100 patients who underwent primary THA in our department. Group A consisted of 50 patients who received the selective cyclooxygenase-2 inhibitor celecoxib for 14 days after surgery, while Group B consisted of 50 patients who received SFP plaster for 14 days after surgery. We noted the numerical rating pain intensity scale (NRS) score, body temperature, and adverse effects of the analgesics.

resultsGroups A and B showed no significant difference in NRS scores (p > 0.05). The body temperature was significantly higher in Group B than in Group A on days one, two, three, and five (p < 0.01). In Group A, two patients (4%) showed drug-induced renal dysfunction, and one patient (2%) showed gastrointestinal disturbance. Patients in Group B showed no systemic or local adverse effects.

conclusionsThe application of SFP plaster after THA provided an analgesic effect similar to that obtained with oral celecoxib without causing obvious side effects. Applying an SFP plaster may be an effective solution for postoperative analgesia.

Indexed as

non-steroidal anti-inflammatory drugnumerical rating pain intensity scaleosteoarthritispostoperative analgesias-flurbiprofen

Identifiers

PMID39280551
PMCPMC11398608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.